Purpose The aim of this investigation was to quantitatively compare the novel positron emission tomography (PET) hypoxia marker 2-(2-nitroimidazol- 
Introduction
Oxygen deficiency (hypoxia) is heterogeneously spread in regions of solid tumours as a result of rapid cellular expansion and/or insufficient tumour angiogenesis [1, 2] . Hypoxia has been related to increased malignant progression and metastatic potential of primary carcinomas as well as to resistance to cancer therapies [3, 4] . Strategies to counteract the negative effect of intra-tumoural hypoxia are being evaluated [5] , but not all patients show benefits from such selective treatments. To facilitate treatment guidance in individual patients, a variety of methods have been proposed to measure oxygenation levels in tumoural tissues.
During the last 20 years, a lot of research has been devoted to non-invasive imaging techniques for the detection of hypoxia in solid tumours. One such technique involves positron emission tomography (PET) using radiolabelled nitroimidazoles. In hypoxic environments, these compounds are subject of a reductive metabolism, which causes the formation of reactive intermediates (nitrose and hydroxylamine) that become covalently bound to macromolecular cellular components [6] . Based on this principle, their selective binding to hypoxic cells has already been demonstrated in vitro as well as in vivo [7] [8] [9] [10] .
[ 18 F]Fluoromisonidazole ([ 18 F]FMISO) was the first radiolabelled 2-nitroimidazole derivative proposed for hypoxia imaging with PET [11] . This tracer has been evaluated extensively for the detection of tumour hypoxia both pre-clinically, using different animal models [12] [13] [14] [15] , and clinically, for different cancer types [16] [17] [18] [19] . Other 18 Flabelled nitroimidazoles, such as [ 18 F]FETNIM [20, 21] and [ 18 F]FAZA [22, 23] , have been synthesized and validated as hypoxia markers. However, being more hydrophilic compounds, the latter PET tracers' diffusion into tumoural tissues might be limited [24] . Therefore, a new class of more lipophilic, fluorinated etanidazole compounds (e.g. EF3 and EF5 ) is of potential interest. Preliminary animal experiments involving these fluorinated derivatives indicated more homogeneous distribution in normal tissues together with tracer clearance through the kidneys and tracer accumulation in hypoxic tumours [25, 26] . Recently, Josse et al. successfully radiolabeled 2-(2-nitroimidazol-1-yl)-N-(3,3,3-trifluoropropyl)acetamide (EF3) using 18 F for PET-based hypoxia evaluation [27] . [28] .
The aim of the present study was to quantitatively compare the in vivo hypoxia-dependent uptake of [ 18 F]EF3 and [
18 F]FMISO in experimental rat tumours by noninvasive investigation with PET. The experiments also involved the evaluation of the in vivo pharmacokinetics of both tracers and their biodistribution in normal tissues.
Materials and methods

Animal and tumour model
Male adult WAG/Rij rats with an average body weight of 315 g were used. Each rat was implanted subcutaneously under sodium pentobarbital anaesthesia (Nembutal 0.1 ml 100 g −1 body weight; Sanofi, Belgium) with syngeneic rhabdomyosarcomas (1-mm 3 R1 tumours; [29] ) in the lateral thorax or in the abdominal flank. Tumours were measured every day during the experiment using a Vernier caliper in three orthogonal tumour diameters A, B and C, each corrected for the thickness of the skin. Volumes were calculated using the formula A ×B ×C× π/6, since the tumours grew elliptically. PET measurements were performed within a 2-week follow-up. Procedures were performed according to the guidelines defined in the "Principles of laboratory animal care" (NIH publication no. 86-23, revised 1985) . All animals were maintained in a facility which was approved by the Belgian Ministry of Agriculture in accordance to current regulations and standards. Animals were given food and water ad libitum for the duration of the experiments. The experimental design was approved by the Animal Ethics Committee of the Katholieke Universiteit Leuven, Leuven (FMISO experiment) and of the Université Catholique de Louvain, Louvain-la-Neuve (EF3 experiment). (Fig. 1a ) was synthesised as previously described [27] . Briefly, the radiolabelled perfluorinated aminodithioester precursor group was de-protected and coupled to 2-nitroimidazole acetic acid to generate [ 18 F]EF3, which was isolated by reverse phase semi-preparative high-perfor-mance liquid chromatography (HPLC (Fig. 1b) was produced by the nucleophilic substitution of 1-(2′-nitro-1′-imidazolyl)-2-O-tetrahydropyranyl-3-O-toluenesulfonylpropandiole with [ 18 F]fluoride followed by acidic hydrolysis of the protecting group, as described by Lim and Berridge [30] . Radiochemical purity was always higher than 95%; specific radioactivity was higher than 37,000 GBq/mmol. ), a dynamic emission scanning (26 frames) to obtain heart outflow clearance data was started for 60 min, according to the following protocol: 8×15 s, 4×30 s, 2×1 min, 2× 2 min, 10×5 min. Two hours post injection (p.i.), a second dynamic emission scan for 20 min (4×5 min) following repositioning and a 15-min transmission scan were performed as previously described [13] . To allow extensive comparison with [ 18 F]FMISO, the same sequence (transmission followed by 20-min dynamic emission) was repeated twice (3 and 4 h p.i.) on the [
Synthesis of the hypoxia markers
18 F]EF3-injected animals. All images were reconstructed iteratively (2D-OSEM) using attenuation factors obtained from the transmission scans. The images were also corrected for scatter, randoms, deadtime, frame duration and decay to the start of each emission scan. The activity concentrations, obtained in selected tissues from regions of interest (ROI) drawn on the images, were subsequently corrected for decay towards the time of injection.
PET image analysis
Blood pool activity data were obtained by drawing a volume of interest (VOI) with an average diameter of 9 mm on the outflow area of the heart, which was defined with the aid of the early perfusion images. To validate these data, they were compared to the results obtained from the blood samples quantified using ex vivo counting in a gamma counter which was cross-calibrated versus the PET scanner. Blood clearance curves for both tracers were then created by plotting the activity values within each VOI in all single time frames of the dynamic acquisition (expressed as percent of injected dose per gram tissue) against time. Normal tissue evaluation was done using VOI analysis (diameter of 9 mm) on the lung, muscle (as described in [8] ) and head and neck (H&N) area (as described in [31] ). Tracer uptake in tumours was evaluated by VOI analysis on the summed frames at 2, 3 and 4 h p.i. VOIs were defined by drawing isocontours on all slices where visible tumour uptake was present. All activity data were corrected for 18 
Histology
Excised tumours were fixed in neutral buffered formalin (1-4%), embedded in paraffin and cut into 5-μm-thick slices using a Leica-2045 microtome (Germany). Slices were deparaffinised with toluene and rehydrated by treatment with a series of alcohol and water mixtures and finally with water. Tissue sections were stained using Mayer's haematoxylin (Klinipath b.v. Belgium) for 5 min. After incubation in tap water (10 min), the sections were counterstained with eosin (Klinipath b.v. Belgium) for 3 min, dehydrated and mounted. Sections were scored by means of moving a '10×10' gridincorporated ocular, superimposed on the image, at a total magnification of ×200. For each tumour, an average of 807± 319 hit-points were evaluated and the necrotic fraction (NF) was calculated. . Upon euthanasia at 2 or 4 h p.i., tumours were excised, rapidly frozen in 2-methylbutane (cooled to −25°C with liquid nitrogen) and cut with a Leica-CM-3050 cryotome (Germany) into 7-μm-thick sections. Selected tumour sections were mounted onto microscope slides, airdried and exposed overnight to a high-performance storage phosphor screen (Packard, Meriden, USA). The spatial distribution of radioactivity was autoradiographically recorded with a Phosphor Imager Scanner (Packard Cyclone TM, Meriden, USA). The resolution of the images expressed in pixel size was 42×42 μm (600 dpi).
Statistics
All statistical analyses were performed with SPSS 12.0.1 for Windows (SPSS, 2003, Chicago, USA). Graphs were drawn using Origin 6.0 (Microcal Software, 1999, Northampton, USA). Correlation among the variables was analysed using Spearman rank order correlation and additionally evaluated by linear regression. An unpaired Student's t test and non-parametric Mann-Whitney U test for small groups were used to determine the statistical significance of differences between two independent groups of variables. For all tests, a P<0.05 was considered significant.
Results
Heart outflow as reference tissue
Comparison (Fig. 2) of the heart outflow data, defined by VOI-PET analysis on [
18 F]EF3 images with the blood activity data quantified ex vivo in a gamma counter, resulted in a strong, significant correlation (r 2 =0.924; P<0.001; y= 1.006x+34.792). ROI analysis of the heart outflow area was performed independently by a second observer. No significant difference (P=0.986) was seen. Based on these results, the heart outflow was selected as reference tissue for the calculation of the T/B ratios. (Fig. 5a) (Fig. 5b) . On average, the [ 18 F]FMISO tracer uptake was higher compared with the [ 18 F]EF3 uptake.
Discussion
Over the last decade, interest into the development of radiolabelled markers for the non-invasive diagnosis of tumour hypoxia in solid tumours has increased dramatically. Based on its high cellular uptake and trapping in hypoxic cells, [
18
F]FMISO has been tested for in vivo visualization of reduced oxygen tension in tumours, both in pre-clinical [12] [13] [14] [15] and clinical [17, 19] settings. [ 18 F]FMISO has also been indicated to be a valuable tool for therapy response evaluation [16, 18] . However, the diffusion of [
18 F]FMISO into tissues and, in particular, into tumour tissues, which are known to have abnormal vascularisation, might not be optimal due to the hydrophilicity of the compound (octanolto-buffer partition coefficient of 0.4). 18 F]EF3 could be a good candidate for the detection of tumour hypoxia [28] . The use of [ 18 F]EF3 to detect tumour hypoxia has been further validated by comparison with the intracellular EF5 uptake as detected by immunofluorescence [32] . On the other hand, Dubois et al. validated the non-invasive [
18 F]FMISO-PET method to measure tumour hypoxia by comparison with the exogenous hypoxia marker pimonidazole [13] . Further preclinical in vivo evaluation of [ 18 F]EF3 by comparison with other radiolabelled hypoxia tracers is a very important issue. The aim of the present study has been to quantitatively compare the selectivity of hypoxia-dependent uptake of both tracers in the same experimental rat tumour model using in vivo PET.
We evaluated the potential use of the heart 'outflow' ROI as "reference tissue" to avoid retro-orbital sampling of blood, a procedure which may cause radioactive contamination and which may interfere with the quality of life of the animals particularly when performed repeatedly. Moreover, the heart 'outflow' ROI was preferred as reference rather than muscle, since tracer uptake in muscle tissue might be sensitive to changes in oxygenation status [20] . Lehtiö Some studies showed heterogeneity in larger tumours and a more uniform tracer distribution in smaller tumours [12, 20] . In a previous study, we showed, however, heterogeneity of [ 18 F]FMISO uptake both in small and large rhabdomyosarcoma tumours [13] [20] or the more lipophilic tracer EF5 [38] has been shown to be independent of the tumour volume. Based on histological evaluation of tumour necrosis, we found a correlation between the tumour volume and NF with a clear significant separation in NF between tumours smaller and larger than 1 cm 3 . Although a statistical difference was observed between the NF of both groups, mean and maximum tracer uptake were also independent of the tumour volume when analysing both groups separately. Also, in this case, [ 18 F]EF3 uptake demonstrated a better correlation with tumour volume compared with [ 18 F]FMISO uptake. The overall trend, however, indicates the use of maximum activity data, since Stadler et al. demonstrated that the maximum level of FMISO uptake is most closely related to the biological changes induced by the genomic instability associated with hypoxia and may reflect the severity of hypoxia [39] . In addition, it has been shown recently that FMISO maximum T/B ratios were highly predictive in a multivariate analysis [17] and lead to an enhancement of the reproducibility of the measurements together with a reduced effect of the partial volume effects [40] . 
Conclusion
